Company / Capital Expenditures
PURE BIOSCIENCE, INC. Capital Expenditures History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$33.0K
FY2023
5-year range
$33.0K / $521.0K
FY2019-FY2023
Trend
-59.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $521,000 to $33,000 over the past 2 years.
Based on SEC 10-K filings.
$33,000 in FY2023 with a 5-year CAGR of +11.7%.
Declined from $521,000 to $33,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -17.1%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +11.7%, indicating consistent growth.
- In FY2023, capital expenditures decreased 59.3% year-over-year.
- Peak capital expenditures was recorded in FY2021.
- Lowest capital expenditures in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $33.0K | -59.3% |
| FY2022 | $81.0K | -84.5% |
| FY2021 | $521.0K | +798.3% |
| FY2020 | $58.0K | +728.6% |
| FY2019 | $7.0K | -63.2% |
| FY2018 | $19.0K | -90.8% |
| FY2017 | $206.0K | -47.2% |
| FY2016 | $390.0K | +381.5% |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026